近三分之二的美国医生正在使用一款AI驱动的搜索引擎来做出患者决策，推动一家鲜为人知的科技初创公司估值达到150亿美元，同时引发了关于未来患者护理的争论。
Nearly two-thirds of US doctors are turning to an AI-powered search engine to make patient decisions, propelling a little-known tech startup to a $15 billion valuation while prompting a debate over the future of patient care.
总部位于迈阿密的OpenEvidence由连续创业者丹尼尔·纳德勒于2022年创立，该公司表示，美国约100万名医生中有许多上个月处理了超过4200万个提示。医生们正在使用该公司的聊天机器人来搜索医学期刊和临床指南，以帮助诊断和治疗患者。
Miami-based OpenEvidence, founded by serial entrepreneur Daniel Nadler in 2022, said that many of America’s 1 million physicians processed more than 42 million prompts last month. Doctors are using the company’s chatbot to scour medical journals and clinical guidelines to help diagnose and treat patients.
这个由广告驱动的平台主要通过口碑增长，在很少有工具获得类似吸引力的领域中渗透。“我们是医疗保健领域第一个病毒式传播的消费互联网应用，”纳德勒在接受《金融时报》采访时表示。
The ads-powered platform has grown largely by word of mouth, penetrating a sector where few tools have seen similar traction. “We’re the first viral consumer internet app in healthcare,” Nadler told the FT in an interview.